Amoxicillin Clavulanate in Treatment of Acute Otitis Media
Status:
Unknown status
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, double-blind, placebo controlled one-center study carried
out in primary care setting of the health center of City of Turku, Finland. The study
patients will be allocated to one of the two parallel treatment groups
(amoxicillin-clavulanate or placebo). The hypothesis is that the symptoms and signs of acute
otitis media are resolved more effectively with antimicrobial treatment than with placebo.
Furthermore, this study aims at finding out prognostic factors that could help to direct
antimicrobial treatment for correct subgroups of young patients.
Phase:
Phase 4
Details
Lead Sponsor:
University of Turku
Collaborators:
Finnish Institute for Health and Welfare National Institute for Health and Welfare, Finland